Bionova Capital, previously known as Hovione Capital, is a healthcare-focused venture capital firm, investing in early-stage life science companies. It was founded in 2015 by the shareholders of Hovione, one of the largest pharmaceutical companies in Portugal, with manufacturing and research operations in USA, Ireland, China and Portugal. Bionova Capital invests in groundbreaking therapeutics, medtech and digital health startups across Europe.
Location: Portugal, Lisbon
Employees: 1-10
Founded date: 2015
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A
Portfolio 6
| Date | Name | Website | Total Raised | Location |
| - | CellmAbs | cellmabs.c... | - | Portugal, ... |
| - | Adapttech | adapttech.... | $10.17M | Portugal, ... |
| - | SolasCure | solascure.... | $34.16M | United Kin... |
| - | Vaxdyn | vaxdyn.com | - | Spain, And... |
| - | Anybrain | anybrain.g... | - | Portugal, ... |
| - | Delox | delox.pt | - | Portugal, ... |
Mentions in press and media 1
| Date | Title | Description | Source |
| 23.03.2021 | Birmingham/Porto-based medtech Adapttech raises £2 million | A fresh round of funding will be used to fuel new technology developments and increase sales at Birm... | tech.eu/br... |